You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
華潤醫藥(03320.HK):博雅生物6933.2萬股股份完成轉讓予華潤醫藥控股
格隆匯 07-15 21:08

格隆匯7月15日丨華潤醫藥(03320.HK)公吿,深圳證券交易所的審核及合規性確認以及向中國證券登記結算有限責任公司深圳分公司申請辦理股份過户登記手續已完成。因此,於2021年7月15日,根據交易文件及補充交易文件的條款及條件,已完成建議轉讓目標公司博雅生物製藥集團股份有限公司(300294.SZ)6933.2萬股非限售流通股股份予華潤醫藥控股。

於完成建議轉讓後,根據交易文件及補充交易文件的條款及條件,建議將表決權委託予華潤醫藥控股已即時生效。於完成建議轉讓及完成建議表決權委託後,華潤醫藥控股持有目標公司於本公吿日期的總股本約29.17%表決權。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account